よむ、つかう、まなぶ。
資料２ 東委員提出資料＜公開＞ (6 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_75738.html |
| 出典情報 | 厚生科学審議会 がん登録部会（第37回 8／24）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
希少がんの分析では網羅的データが特に有用
全国がん登録により、希少がん分析は推計から実測値による正確な罹患率算出、十分な症例数把握が可能に
⇒ 従来十分な症例数を確保しにくかったがん種において、全国規模での罹患率、年齢分布、治療実態、予後因子の
検討が数多くなされている。
・Satake T, Morizane C, Rikitake R, Higashi T, Okusaka T, Kawai A. The epidemiology of rare types of hepatobiliary and pancreatic cancer from
＜希少がん研究の報告例＞
• 骨外Ewing肉腫
• 腎臓の肉腫
• 脂肪肉腫
• 明細胞腫瘍
• 神経内分泌腫瘍
• 消化管間質性腫瘍
• 頭頚部がん
など
national cancer registry. J Gastroenterol 2022;57:890-901.
・Ogata D, Namikawa K, Nakano E, et al. Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017. Cancer Sci
2023;114:2986-92.
・Ogura K, Morizane C, Satake T, et al. Statistics of bone sarcoma in Japan: report from the population-based cancer registry in Japan. Int J
Clin Oncol 2024;29:1209-19.
・Ogura K, Morizane C, Satake T, et al. Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019. Jpn J Clin
Oncol 2024;54:1150-7.
・Rikitake R, Mizushima Y, Yoshimoto S, et al. Current status of head and neck sarcomas in Japan in 2016-2019: an analysis using the
national cancer registry. Int J Clin Oncol 2024;29:564-70.
・Takemori T, Ogura K, Morizane C, et al. Clear cell sarcoma in Japan: an analysis of the population-based cancer registry in Japan. Jpn J Clin
Oncol 2024;54:1281-7.
・Hirano H, Naito Y, Nishida T, et al. Epidemiologic Features and Age-Related Differences in Management among Patients with Gastrointestinal
ondo H, Ogura K, Morizane C, et al. Chondrosarcoma in Japan: an Stromal Tumors in Japan: A National Cancer Registry Study. Cancer Res
Commun 2025;5:1235-42.
・Kanalytic study using population-based National Cancer Registry. Jpn J Clin Oncol 2025;55:490-7.
・Muramatsu S, Ogura K, Morizane C, et al. Statistics of Visceral Sarcoma in Japan: Report From the Population-Based National Cancer
Registry (NCR) in Japan. J Surg Oncol 2025;131:274-84.
・Ogata D, Namikawa K, Nakano E, et al. Comprehensive epidemiology of melanoma at all sites: insights from Japan's National Cancer
Registry, 2016-2017. Int J Clin Oncol 2025;30:194-8.
・Ogura K, Morizane C, Satake T, et al. Incidence and age- and site-specific characteristics of osteosarcoma: a population-based study using
National Cancer Registry 2016-2019. Jpn J Clin Oncol 2025;55:1037-45.
・Takemori T, Ogura K, Morizane C, et al. Epidemiology and Outcomes of Retroperitoneal Sarcoma: An Analysis of the Population-Based
Cancer Registry in Japan 2016-2019. J Surg Oncol 2025;132:1106-15.
・Takemori T, Ogura K, Morizane C, et al. Incidence and site specific characteristics of angiosarcoma in Japan using a population-based
national cancer registry from 2016 to 2019. Sci Rep 2025;15:9960.
・Toda Y, Ogura K, Morizane C, et al. Prognostic factors and management of elderly sarcoma in Japan: the population-based National Cancer
Registry (NCR) in Japan. Int J Clin Oncol 2025;30:1018-32.
・Kondo H, Ogura K, Morizane C, et al. Clinical Characteristics and Prognostic Factors of Renal Sarcoma: A Japanese National Cancer Registry
Study. Cancer Invest 2026;44:516-25.
・Kondo H, Ogura K, Morizane C, et al. Subtype-specific characteristics and outcomes of liposarcoma: A population-based study using Japan's
National Cancer Registry. J Orthop Sci 2026;31:916-23.
・Muramatsu S, Ogura K, Morizane C, et al. Epidemiology and prognosis of malignant peripheral nerve sheath tumor (MPNST) in Japan: A
population-based analysis using the national cancer registry. J Orthop Sci 2026;31:473-9.
6
全国がん登録により、希少がん分析は推計から実測値による正確な罹患率算出、十分な症例数把握が可能に
⇒ 従来十分な症例数を確保しにくかったがん種において、全国規模での罹患率、年齢分布、治療実態、予後因子の
検討が数多くなされている。
・Satake T, Morizane C, Rikitake R, Higashi T, Okusaka T, Kawai A. The epidemiology of rare types of hepatobiliary and pancreatic cancer from
＜希少がん研究の報告例＞
• 骨外Ewing肉腫
• 腎臓の肉腫
• 脂肪肉腫
• 明細胞腫瘍
• 神経内分泌腫瘍
• 消化管間質性腫瘍
• 頭頚部がん
など
national cancer registry. J Gastroenterol 2022;57:890-901.
・Ogata D, Namikawa K, Nakano E, et al. Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017. Cancer Sci
2023;114:2986-92.
・Ogura K, Morizane C, Satake T, et al. Statistics of bone sarcoma in Japan: report from the population-based cancer registry in Japan. Int J
Clin Oncol 2024;29:1209-19.
・Ogura K, Morizane C, Satake T, et al. Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019. Jpn J Clin
Oncol 2024;54:1150-7.
・Rikitake R, Mizushima Y, Yoshimoto S, et al. Current status of head and neck sarcomas in Japan in 2016-2019: an analysis using the
national cancer registry. Int J Clin Oncol 2024;29:564-70.
・Takemori T, Ogura K, Morizane C, et al. Clear cell sarcoma in Japan: an analysis of the population-based cancer registry in Japan. Jpn J Clin
Oncol 2024;54:1281-7.
・Hirano H, Naito Y, Nishida T, et al. Epidemiologic Features and Age-Related Differences in Management among Patients with Gastrointestinal
ondo H, Ogura K, Morizane C, et al. Chondrosarcoma in Japan: an Stromal Tumors in Japan: A National Cancer Registry Study. Cancer Res
Commun 2025;5:1235-42.
・Kanalytic study using population-based National Cancer Registry. Jpn J Clin Oncol 2025;55:490-7.
・Muramatsu S, Ogura K, Morizane C, et al. Statistics of Visceral Sarcoma in Japan: Report From the Population-Based National Cancer
Registry (NCR) in Japan. J Surg Oncol 2025;131:274-84.
・Ogata D, Namikawa K, Nakano E, et al. Comprehensive epidemiology of melanoma at all sites: insights from Japan's National Cancer
Registry, 2016-2017. Int J Clin Oncol 2025;30:194-8.
・Ogura K, Morizane C, Satake T, et al. Incidence and age- and site-specific characteristics of osteosarcoma: a population-based study using
National Cancer Registry 2016-2019. Jpn J Clin Oncol 2025;55:1037-45.
・Takemori T, Ogura K, Morizane C, et al. Epidemiology and Outcomes of Retroperitoneal Sarcoma: An Analysis of the Population-Based
Cancer Registry in Japan 2016-2019. J Surg Oncol 2025;132:1106-15.
・Takemori T, Ogura K, Morizane C, et al. Incidence and site specific characteristics of angiosarcoma in Japan using a population-based
national cancer registry from 2016 to 2019. Sci Rep 2025;15:9960.
・Toda Y, Ogura K, Morizane C, et al. Prognostic factors and management of elderly sarcoma in Japan: the population-based National Cancer
Registry (NCR) in Japan. Int J Clin Oncol 2025;30:1018-32.
・Kondo H, Ogura K, Morizane C, et al. Clinical Characteristics and Prognostic Factors of Renal Sarcoma: A Japanese National Cancer Registry
Study. Cancer Invest 2026;44:516-25.
・Kondo H, Ogura K, Morizane C, et al. Subtype-specific characteristics and outcomes of liposarcoma: A population-based study using Japan's
National Cancer Registry. J Orthop Sci 2026;31:916-23.
・Muramatsu S, Ogura K, Morizane C, et al. Epidemiology and prognosis of malignant peripheral nerve sheath tumor (MPNST) in Japan: A
population-based analysis using the national cancer registry. J Orthop Sci 2026;31:473-9.
6